1. 1) Paice B. J., Paterson K. R., Onyanga-Omara F., Donnelly T., Gray J. M., Lawson D. H., Postgrad. Med. J., 62, 187-191 (1986).
2. 2) Viera A. J., Wouk N., Am. Fam. Physician, 92, 487-495 (2015).
3. 3) Shibagaki Y., “Yori Rikai o Fukameru! Taiekidenkaishitsu Ijyo to Yueki,” ed. by Chugai-Igakusha, Tokyo, 2010, pp. 88-119.
4. 4) ZOSYN® Interview form, 21st ed., Taiho Pharmaceutical & Co., Ltd., April 2019: 〈http://www.info.pmda.go.jp/go/interview/1/400107_6139505F3020_1_01A_1F.pdf〉, cited 29 July, 2019.
5. 5) The Japanese Association for Infectious Diseases (JAID), Japanese Society of Chemotherapy (JSC), “The JAID/JSC Guide to Clinical Management of Infectious Diseases 2014,” JAID, JSC, Tokyo, 2014, pp. 5-112.